This inventor holds 1 USPTO granted patent. Top assignee: Minoryx Therapeutics S.l.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Alan Bye: Innovator in Therapeutic Methods
Introduction
Alan Bye is a notable inventor based in Horsham, GB. He has made significant contributions to the field of therapeutics, particularly in the development of methods for administering effective treatments for various diseases. His work is characterized by a focus on innovative solutions that address complex medical challenges.
Latest Patents
Alan Bye holds a patent for a method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione. This patent outlines methods for treating diseases or disorders in patients by administering this compound, which is a PPAR-γ agonist. The compound is utilized in the treatment of conditions such as nonalcoholic steatohepatitis and central nervous system diseases, including X-linked adrenoleukodystrophy and Friedreich's Ataxia.
Career Highlights
Alan Bye is associated with Minoryx Therapeutics S.L., where he continues to advance his research and development efforts. His work at this company reflects his commitment to improving therapeutic options for patients suffering from serious health conditions. His innovative approach has led to the creation of effective treatment methodologies that are crucial in the medical field.
Conclusion
Alan Bye's contributions to therapeutic methods exemplify the impact of innovation in medicine. His patent and ongoing work at Minoryx Therapeutics S.L. highlight his dedication to addressing significant health challenges through inventive solutions.